The polymorphisms and haplotypes of WWOX gene are associated with the risk of lung cancer in southern and eastern chinese populations. Issue 1 (12th June 2012)
- Record Type:
- Journal Article
- Title:
- The polymorphisms and haplotypes of WWOX gene are associated with the risk of lung cancer in southern and eastern chinese populations. Issue 1 (12th June 2012)
- Main Title:
- The polymorphisms and haplotypes of WWOX gene are associated with the risk of lung cancer in southern and eastern chinese populations
- Authors:
- Huang, Dongsheng
Qiu, Fuman
Yang, Lei
Li, Yinyan
Cheng, Mei
Wang, Hui
Ma, Guanpei
Wang, Yunnan
Hu, Min
Ji, Weidong
Zhou, Yifeng
Lu, Jiachun
Angel, Joe - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <sec id="mc21934-sec-0001" sec-type="section"> <p>The WW domain‐containing oxidoreductase (<italic>WWOX</italic>) gene is an identified tumor suppressor gene, of which several single nucleotide polymorphisms have been reported to contribute to cancer susceptibility. We hypothesized that genetic variations in <italic>WWOX</italic> are associated with lung cancer risk. In two independent case–control studies conducted in southern and eastern Chinese, we genotyped five tagSNPs of <italic>WWOX</italic> gene (rs10220974C &gt; T, rs3764340C &gt; G, rs12918952G &gt; A, rs383362G &gt; T, and rs12828G &gt; A) in 1, 559 lung cancer cases and 1, 679 controls. Logistic regression analysis showed that two tagSNPs (rs3764340C &gt; G; rs383362G &gt; T) were significantly associated with lung cancer risk in dominant model (rs3764340C &gt; G, GC/GG vs. CC: adjust OR = 1.35, 95% CI = 1.11–1.65; rs383362G &gt; T, TG + TT vs. GG: adjust OR = 1.33, 95% CI = 1.14–1.55). The haplotype analysis further shown that the haplotype "G‐T" was associated with the highest increased risk of lung cancer (OR = 2.20; 95% CI = 1.43–3.37). After combined these two loci, the number of the risk genotypes was associated with increased cancer risk in a dose–response manner (<italic>P</italic><sub>trend</sub> = 3.16 × 10<sup>−6</sup>). In addition, a gene‐based association analysis by using VEGAS software suggested the <italic>WWOX</italic> as a<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <sec id="mc21934-sec-0001" sec-type="section"> <p>The WW domain‐containing oxidoreductase (<italic>WWOX</italic>) gene is an identified tumor suppressor gene, of which several single nucleotide polymorphisms have been reported to contribute to cancer susceptibility. We hypothesized that genetic variations in <italic>WWOX</italic> are associated with lung cancer risk. In two independent case–control studies conducted in southern and eastern Chinese, we genotyped five tagSNPs of <italic>WWOX</italic> gene (rs10220974C &gt; T, rs3764340C &gt; G, rs12918952G &gt; A, rs383362G &gt; T, and rs12828G &gt; A) in 1, 559 lung cancer cases and 1, 679 controls. Logistic regression analysis showed that two tagSNPs (rs3764340C &gt; G; rs383362G &gt; T) were significantly associated with lung cancer risk in dominant model (rs3764340C &gt; G, GC/GG vs. CC: adjust OR = 1.35, 95% CI = 1.11–1.65; rs383362G &gt; T, TG + TT vs. GG: adjust OR = 1.33, 95% CI = 1.14–1.55). The haplotype analysis further shown that the haplotype "G‐T" was associated with the highest increased risk of lung cancer (OR = 2.20; 95% CI = 1.43–3.37). After combined these two loci, the number of the risk genotypes was associated with increased cancer risk in a dose–response manner (<italic>P</italic><sub>trend</sub> = 3.16 × 10<sup>−6</sup>). In addition, a gene‐based association analysis by using VEGAS software suggested the <italic>WWOX</italic> as a susceptible gene for lung cancer (<italic>P </italic>= 0.009). However, for rs10220974C &gt; T, rs12918952G &gt; A, and rs12828G &gt; A, no significant association was observed for lung cancer risk. Taken together, our data suggested that genetic variants in <italic>WWOX</italic> may be genetic biomarkers for susceptibility to lung cancer. Copyright © 2012 Wiley Periodicals, Inc.</p> </sec> </abstract> … (more)
- Is Part Of:
- Molecular carcinogenesis. Volume 52:Issue 1(2013:Jan.)
- Journal:
- Molecular carcinogenesis
- Issue:
- Volume 52:Issue 1(2013:Jan.)
- Issue Display:
- Volume 52, Issue 1 (2013)
- Year:
- 2013
- Volume:
- 52
- Issue:
- 1
- Issue Sort Value:
- 2013-0052-0001-0000
- Page Start:
- 19
- Page End:
- 27
- Publication Date:
- 2012-06-12
- Subjects:
- Carcinogenesis -- Molecular aspects -- Periodicals
616.994071 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2744 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/mc.21934 ↗
- Languages:
- English
- ISSNs:
- 0899-1987
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.802000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3997.xml